Analysis of the IKKβ/NF-κ;B signaling pathway during embryonic angiogenesis

Developmental Dynamics

Volumn 237, Issue 10, 2008, Pages 2926-2935

  Hou, Yanjun ^a   Li, Fu ^a   Karin, Michael ^b   Ostrowski, Michael C ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b San Diego   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Development; IKK (I B kinase)

Indexed keywords

ANGIOPOIETIN RECEPTOR; CRE RECOMBINASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FETUS; FETUS LIVER; GENE DELETION; GENE DISRUPTION; GENE LOCUS; HEMATOPOIESIS; LETHALITY; LIVER BLOOD VESSEL; LIVER CELL; LIVER SINUSOID; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; TRANSGENE; ANIMAL; ANIMAL EMBRYO; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LETHAL GENE; METABOLISM; MOUSE MUTANT; PRENATAL DEVELOPMENT; REPORTER GENE; VASCULARIZATION;

ANIMALS; CELL PROLIFERATION; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, LETHAL; GENES, REPORTER; I-KAPPA B KINASE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 54549106779     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21723     Document Type: Article

References (38)

1. Bonizzi G, Karin M. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280-288.
2. Braet F, Wisse E. 2002. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 1:1.
3. Chen F, Castranova V. 2007. Nuclear factor-kappaB, an unappreciated tumor suppressor. Cancer Res 67:11093-11098.
4. Chilov D, Kukk E, Taira S, Jeltsch M, Kaukonen J, Palotie A, Joukov V, Alitalo K. 1997. Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 272:25176-25183.
5. Cleaver O, Melton DA. 2003. Endothelial signaling during development. Nat Med 9:661-668.
6. Couvelard A, Scoazec JY, Dauge MC, Bringuier AF, Potet F, Feldmann G. 1996. Structural and functional differentiation of sinusoidal endothelial cells during liver organogenesis in humans. Blood 87:4568-4580.
7. Edwards S, Lalor PF, Nash GB, Rainger GE, Adams DH. 2005. Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes. Hepatology 41:451-459.
8. Godin I, Cumano A. 2005. Of birds and mice: hematopoietic stem cell development. Int J Dev Biol 49:251-257.
9. Hacker H, Karin M. 2006. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006:re13.
10. Harimoto M, Yamato M, Hirose M, Takahashi C, Isoi Y, Kikuchi A, Okano T. 2002. Novel approach for achieving double-layered cell sheets co-culture: overlaying endothelial cell sheets onto monolayer hepatocytes utilizing temperature-responsive culture dishes. J Biomed Mater Res 62:464-470.
11. Hayashi S, Lewis P, Pevny L, McMahon AP. 2002. Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech Dev 119(suppl 1):S97-S101.
12. Hayden MS, Ghosh S. 2008. Shared principles in NF-kappaB signaling. Cell 132:344-362.
13. Ishdorj G, Graham BA, Hu X, Chen J, Johnston JB, Fang X, Gibson SB. 2008. Lysophosphatidic acid (LPA) protected cancer cells from histone deacetylase(HDAC) Inhibitor-induced apoptosis through activation of HDAC. J Biol Chem (in press).
14. Kellendonk C, Opherk C, Anlag K, Schutz G, Tronche F. 2000. Hepatocyte-specific expression of Cre recombinase. Genesis 26:151-153.
15. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230:230-242.
16. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. 1995. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517-519.
17. Kurosawa Y, Taniguchi A, Okano T. 2005. Novel method to examine hepatocyte-specific gene expression in a functional coculture system. Tissue Eng 11:1650-1657.
18. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N. 2003. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 299:890-893.
19. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. 1999a. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321-325.
20. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M. 1999b. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189:1839-1845.
21. Li ZW, Omori SA, Labuda T, Karin M, Rickert RC. 2003. IKK beta is required for peripheral B cell survival and proliferation. J Immunol 170:4630-4637.
22. Luedde T, Assmus U, Wustefeld T, Meyer zu Vilsendorf A, Roskams T, Schmidt-Supprian M, Rajewsky K, Brenner DA, Manns MP, Pasparakis M, Trautwein C. 2005. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 115:849-859.
23. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. 2001. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294:559-563.
24. Mojzis J, Varinska L, Mojzisova G, Kostova I, Mirossay L. 2008. Antiangiogenic effects of flavonoids and chalcones. Pharmacol Res 57:259-265.
25. Motoike T, Loughna S, Perens E, Roman BL, Liao W, Chau TC, Richardson CD, Kawate T, Kuno J, Weinstein BM, Stainier DY, Sato TN. 2000. Universal GFP reporter for the study of vascular development. Genesis 28:75-81.
26. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
27. Risau W, Flamme I. 1995. Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91.
28. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453:807-811.
29. Sainson RC, Johnston DA, Chu HC, Holderfield MT, Nakatsu MN, Crampton SP, Davis J, Conn E, Hughes CC. 2008. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 111:4997-5007.
30. Stetler-Stevenson WG. 1999. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103:1237-1241.
31. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
32. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV. 1999. Embryonic lethality, liver degeneration, and impaired NFkappa B activation in IKK-beta-deficient mice. Immunity 10:421-429.
33. Tanjore H, Zeisberg EM, Gerami-Naini B, Kalluri R. 2008. Beta1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis. Dev Dyn 237:75-82.
34. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM Jr, Billiar TR, Geller DA. 1998. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273:15148-15156.
35. van Beijnum JR, Buurman WA, Griffioen AW. 2008. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11:91-99.
36. Wei G, Guo J, Doseff AI, Kusewitt DF, Man AK, Oshima RG, Ostrowski MC. 2004. Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model. J Immunol 173:1374-1379.
37. Yasuda M, Shimizu S, Ohhinata K, Naito S, Tokuyama S, Mori Y, Kiuchi Y, Yamamoto T. 2002. Differential roles of ICAM-1 and E-selectin in polymorphonuclear leukocyte-induced angiogenesis. Am J Physiol Cell Physiol 282:C917-C925.
38. Zhou A, Scoggin S, Gaynor RB, Williams NS. 2003. Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference. Oncogene 22:2054-2064.